Molecular Templates Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Molecular Templates Stock Summary

Molecular Templates competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, and Transcode Therapeutics. Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. Molecular Templates operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 228 people.

Molecular Templates Key Financial Ratios

Molecular Templates Key Balance Sheet Accounts

Molecular Templates Key Income Statement Accounts

Molecular Templates Key Cash Accounts

Molecular Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Molecular Templates's current stock value. Our valuation model uses many indicators to compare Molecular Templates value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Molecular Templates competition to find correlations between indicators driving Molecular Templates's intrinsic value. More Info.Molecular Templates is rated below average in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . At this time, Molecular Templates' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Molecular Templates by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Molecular Templates Systematic Risk

Today, most investors in Molecular Templates Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Molecular Templates' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Molecular Templates growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Molecular Templates help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Molecular Templates. We use our internally-developed statistical techniques to arrive at the intrinsic value of Molecular Templates based on widely used predictive technical indicators. In general, we focus on analyzing Molecular Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Molecular Templates's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molecular Templates. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Molecular Stock, please use our How to Invest in Molecular Templates guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Templates. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Templates listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Molecular Templates is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Templates' value that differs from its market value or its book value, called intrinsic value, which is Molecular Templates' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Templates' market value can be influenced by many factors that don't directly affect Molecular Templates' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Molecular Templates' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Templates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Templates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.